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Sepsis represents a serious challenge to public 
health, accounting for  750,000 hospitali  za-
tions and 215,000 deaths annually in the United 
States alone (1, 2). The overall mortality is  30%, 
rising to 40% in the elderly, and is >50% in 
patients with septic shock (1). Septic shock is 
  associated with abnormal coagulation, pro-
found and unresponsive hypotension, vasodi-
latory shock, and multiple organ failure. Sepsis 
de    scribes a complex clinical syndrome that re-
sults from a harmful or damaging host   response 
to microbial infection due to a dysregulated in-
nate immune reaction, which is characterized 
by an excessive production of proinfl  ammat    -
ory cytokines, such as TNF-α and IL-1β (3, 
4). Mononuclear cells play a key role in the 
synthesis of proinfl  ammatory cytokines, partic-
ularly TNF-α, IL-1β, and IL-6, as well as an 
array of other infl  ammatory medi  ators. These 
proinfl  ammatory cytokines can in turn trigger 
secondary infl  ammatory cascades, including the 
production of cytokines, lipid mediators, and 
reactive oxygen species, as well as the up-regu-
lation of cell adhesion molecules that facilitate 
the migration of infl  ammatory cells into tissues. 
By inducing the expression of inducible nitric 
oxide synthase and augmenting the production 
of nitric oxide, proinfl  ammatory cytokines can 
decrease systemic vascular resistance, resulting 
in profound hypotension. Moreover, these cy-
tokines also stimulate the procoagulation path-
way, leading to thrombosis of microvasculature 
and impaired tissue perfusion. The combination 
of hypotension and microvascular occlusion re-
sults in tissue ischemia and ultimately leads to 
multiple organ failure.
The infl  ammatory responses to microbial 
in  fection are initiated by innate immunity 
via Toll-like receptors (TLRs) that recognize 
the pathogen-associated molecular patterns 
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Septic shock is a leading cause of morbidity and mortality. However, genetic factors pre-
disposing to septic shock are not fully understood. Excessive production of proinfl  ammatory 
cytokines, particularly tumor necrosis factor (TNF)-𝗂, and the resultant severe hypotension 
play a central role in the pathophysiological process. Mitogen-activated protein (MAP) 
kinase cascades are crucial in the biosynthesis of proinfl  ammatory cytokines. MAP kinase 
phosphatase (MKP)-1 is an archetypal member of the dual specifi  city protein phosphatase 
family that dephosphorylates MAP kinase. Thus, we hypothesize that knockout of the Mkp-1 
gene results in prolonged MAP kinase activation, augmented cytokine production, and 
increased susceptibility to endotoxic shock. Here, we show that knockout of Mkp-1 sub-
stantially sensitizes mice to endotoxic shock induced by lipopolysaccharide (LPS) challenge. 
We demonstrate that upon LPS challenge, Mkp-1−/− cells exhibit prolonged p38 and c-Jun 
NH2-terminal kinase activation as well as enhanced TNF-𝗂 and interleukin (IL)-6 produc-
tion compared with wild-type cells. After LPS challenge, Mkp-1 knockout mice produce 
dramatically more TNF-𝗂, IL-6, and IL-10 than do wild-type mice. Consequently, Mkp-1 
knockout mice develop severe hypotension and multiple organ failure, and exhibit a re-
markable increase in mortality. Our studies demonstrate that MKP-1 is a pivotal feedback 
control regulator of the innate immune responses and plays a critical role in suppressing 
endotoxin shock.
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  characteristic of microbial products (5). The infl  ammatory 
response to LPS is mediated mainly by a receptor complex 
composed of LPS-binding protein CD14 and TLR4, which 
is critically important in the innate immune recognition of 
Gram-negative pathogens (6). Upon activation of TLR4, 
the adaptor protein MyD88 is recruited to the receptor, 
which in turn triggers a cascade of signaling events leading 
to the activation of transcription factor NF-κB and mito-
gen-activated protein (MAP) kinases. NF-κB plays a pivotal 
role in the transcription of a variety of proinfl  ammatory cy-
tokines, including TNF-α, IL-1β, and IL-6. MAP kinases, 
including extracellular signal–regulated kinase (ERK), c-
Jun NH2-terminal kinase (JNK), and p38, also modulate cy-
tokine expression at multiple levels. ERK is required for the 
transport of TNF-α mRNA from the nucleus to the cyto    -
plasm. Knockout mice defi   cient in the proto-oncogene 
Tpl-2 demonstrate defects in ERK activation in response to 
LPS as well as exhibit a substantial attenuation in circulatory 
TNF-α levels after LPS challenge and marked resistance to 
LPS-induced shock (7). p38 is also a crucial mediator for the 
production of proinfl  ammatory cytokines (8) and has been 
identifi  ed as the target of a class of small molecule   inhibitors 
capable of inhibiting the production of infl  am  matory cyto-
kines (9). Furthermore, knockout of MAP kinase–activated 
protein kinase 2 (MK2), a downstream target of p38, abol-
ishes the production of proinfl  ammatory cytokines and pro-
tects mice from LPS-induced mortality (10). It has been 
shown that p38 may mediate TNF-α production by en-
hancing the stability of TNF-α mRNA and accelerating its 
translation (11, 12).
Because a group of dual specifi  city MAP kinase phospha-
tases (MKPs) play a pivotal role in the feedback control of 
MAP kinases, we hypothesize that MKPs act to dephosphor-
ylate and inactivate MAP kinase, thus restraining the pro-
duction of proinfl  ammatory cytokines and preventing sep    tic 
shock. Previously, we have shown that MKP-1 is induced 
by bacterial products and plays an important role in the regu-
lation of TNF-α production in isolated macrophages (13, 
14). In this report, we have studied the physiological func  -
tion of MKP-1 in vivo during the infl  ammatory responses to 
LPS using Mkp-1 knockout mice. Our studies indicate that 
MKP-1 is a pivotal feedback control regulator of innate im-
mune responses and plays a critical role in suppressing endo-
toxic shock.
RESULTS
MKP-1 is responsible for the attenuation of both JNK and 
p38 after LPS stimulation
To examine the physiological function of MKP-1 in the reg-
ulation of the innate immune responses during bacterial in-
fection, thioglycollate-elicited peritoneal macrophages from 
both Mkp-1+/+ and Mkp-1−/− mice were stimulated with 
LPS. In Mkp-1+/+ macrophages, LPS stimulation resulted in 
an increase in MKP-1 protein levels within 30 min, with 
levels peaking at  60 min. The increase of the MKP-1 level 
temporally coincided with the inactivation of p38, JNK, and 
ERK (Fig. 1 A). No MKP-1 protein was detected in the 
Mkp-1−/− macrophages, even with LPS stimulation (Fig. 1 A, 
top). Mkp-1−/− cells exhibited substantially prolonged p38 
and JNK activation compared with Mkp-1+/+ macrophages 
(Fig. 1 A). However, the activation kinetics of ERK were 
similar in both cell groups, indicating that MKP-1 does not 
play a signifi  cant role in ERK inactivation in this system. 
MK2, often referred to as MAP kinase–activated protein ki-
nase 2, is a physiological target of p38 (15). MK2 plays a criti-
cal role in the innate immune response to bacterial infection 
and is required for the production of many infl  ammatory 
  cytokines in vivo after LPS challenge (10). Consistent with 
the sustained p38 activation in Mkp-1−/− macrophages, LPS 
stimulation also resulted in a prolonged MK2 activation in 
Mkp-1−/− macrophages (Fig. 1 A, third panel). The fi  ndings 
that Mkp-1–defi  cient cells had sustained p38 and JNK activ-
ities after LPS stimulation were reinforced by detailed analysis 
of the activation kinetics of p38, JNK, and ERK (Fig. 1 B). 
Figure 1.  Mkp-1 defi  ciency results in prolonged p38 and JNK ac-
tivation. (A) The kinetics of MAP kinase activation in Mkp-1+/+ and Mkp-
1−/− macrophages after LPS stimulation. Elicited peritoneal macrophages 
from both Mkp-1+/+ and Mkp-1−/− mice were stimulated with 100 ng/ml 
LPS for the indicated times, and cell lysates were analyzed for phospho-
p38, phospho-JNK, phospho-ERK, phospho-MK2, and MKP-1 using West-
ern blotting. (B) Detailed kinetics of p38, JNK, and ERK inactivation after 
LPS challenge. Mkp-1+/+ and Mkp-1−/− samples were processed together, 
with the exception of the initial electrophoresis in which Mkp-1+/+ and 
Mkp-1−/− samples were run on different gels. (C) Comparison of MK2 
activities between Mkp-1+/+ and Mkp-1−/− macrophages using immune 
complex kinase assays. Peritoneal macrophages were treated with 100 ng/ml 
LPS for the indicated times, and MK-2 kinase activity was examined by 
immune complex kinase assays using [γ-32P]ATP and a mouse Hsp25 as 
substrate. Kinase activities were quantitated using a phosphorImager and 
expressed as fold-activation relative to controls.JEM VOL. 203, January 23, 2006  133
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The activity of MK2 was also examined by immune complex 
kinase assays using Hsp25 as a substrate. MK2 activity in 
Mkp-1 knockout macrophages was sustained after LPS stim-
ulation relative to wild-type cells (Fig. 1 C). These results 
clearly indicate that MKP-1 plays a predominant role in the 
termination of the JNK and p38 pathways in vivo.
IFN-γ has been shown to activate macrophages, resulting 
in more robust production of infl  ammatory cytokines (16). 
We found that the pretreatment of resident peritoneal mac-
rophages with IFN-γ inhibited MKP-1 induction by LPS 
and resulted in sustained p38 and JNK activation in LPS-
stimulated resident peritoneal macrophages (Fig. 2). This ob-
servation suggests that IFN-γ may increase the activity of 
macrophages in part through attenuation of MKP-1 induc-
tion. Collectively, our results indicate that MKP-1 is a pri-
mary regulator of MAP kinases, especially p38 and JNK, in 
peritoneal macrophages activated by the Gram-negative bac-
terial cell wall component, LPS.
Mkp-1 defi  ciency alters the pattern of cytokine production 
in LPS-stimulated innate immune cells
Because MAP kinases are pivotal in modulating innate im-
mune responses (17), we investigated the eff  ect of Mkp-1 defi  -
ciency on cytokine production by several diff  erent types of 
innate immune cells. First, resident peritoneal macrophages 
were isolated from Mkp-1+/+ and Mkp-1−/− mice, primed 
with IFN-γ, and stimulated with LPS. The concentrations 
of cytokines secreted into the media were determined by 
ELISA. In the absence of LPS stimulation, TNF-α and IL-6 
production was undetectable (not depicted). In response to 
LPS stimulation, IFN-γ–primed resident peritoneal macro-
phages from Mkp-1−/− mice produced signifi  cantly more TNF-
α and IL-6 than did their wild-type counterparts (Fig. 3 A). 
To assess the role of MKP-1 in cytokine production in infl  am-
matory cells, we elicited both wild-type and Mkp-1−/− mice 
with thioglycollate and isolated peritoneal macrophages from 
these mice. Similar to what was observed for IFN-γ–primed 
resident macrophages, thioglycollate-elicited peritoneal mac-
rophages from Mkp-1−/− mice also mounted a more robust 
TNF-α production than did wild-type cells upon LPS stimu-
lation (Fig. 3 B, top left). Likewise, IL-6 production by thio-
glycollate-elicited Mkp-1−/− peritoneal macrophages was also 
signifi  cantly elevated compared with wild-type cells at 6 h, but 
not at 4 h, likely refl  ecting the delayed expression of IL-6 re-
lative to TNF-α (Fig. 3 B, top right). IL-12 is a classic Th1 
cytokine produced by macrophages that can promote the dif-
ferentiation of naive Th cells into Th1 cells (18). Surprisingly, 
production of IL-12 by thioglycollate-elicited Mkp-1−/− peri-
toneal macrophages in response to LPS was signifi  cantly de-
creased relative to Mkp-1+/+ peritoneal macrophages (Fig. 3 B, 
bottom). Enhanced IL-6 production and attenuated IL-12 
biosynthesis upon LPS stimulation were also observed in un-
primed Mkp-1−/− resident peritoneal macrophages compared 
with their Mkp-1+/+ counterparts (Fig. 3 C).
To study the eff  ect of Mkp-1 defi  ciency on the expression 
of infl  ammatory cytokines, resident peritoneal macrophages 
were isolated from Mkp-1+/+ and Mkp-1−/− mice, primed 
with IFN-γ, and stimulated with LPS for 4 h. The expression 
levels of TNF-α, IL-6, IL-12p35, and IL-12p40 mRNAs 
were assessed by quantitative real-time RT-PCR (qRT-
PCR; Fig. 3 D). TNF-α mRNA levels in the LPS-stimu-
lated Mkp-1−/− macrophages were 3.5-fold higher than those 
in the LPS-stimulated Mkp-1+/+ macrophages. IL-6 mRNA 
levels were  50% higher in the LPS-stimulated Mkp-1−/− 
macrophages than those in their wild-type counterparts. In 
contrast, the expression levels of both IL-12p35 and IL-12p40 
were signifi  cantly decreased in the LPS-stimulated Mkp-1−/− 
macrophages relative to their wild-type counterparts. In fact, 
compared with the mRNA levels in the LPS-stimulated 
wild-type macrophages, IL-12p35 and IL-12p40 mRNA 
levels in the Mkp-1−/− macrophages were decreased by 65 
and 70%, respectively. Therefore, the diff  erence observed in 
cytokine levels in Mkp-1−/− cells is likely due to the modula-
tion of cytokine gene expression.
To understand the role of Mkp-1 in the production of in-
fl  ammatory cytokines in other cell populations, splenocytes 
were isolated from both Mkp-1+/+ and Mkp-1−/− mice and 
stimulated with LPS to assess the eff  ect of Mkp-1 deletion on 
cytokine production. In response to LPS, splenocytes from 
Mkp-1+/+ mice produced considerable amount of TNF-α 
(Fig. 4 A, left). The amount of TNF-α secreted by the Mkp-
1–defi   cient splenocytes was appreciably greater than that 
produced by the Mkp-1+/+ splenocytes (Fig. 4 A, left). How-
ever, compared with the more robust TNF-α production by 
the Mkp-1–defi  cient splenocytes, the production of two clas-
sic Th1 cytokines, IFN-γ and IL-12, was actually attenuated 
in these cells relative to that in the wild-type splenocytes (Fig. 
4 A, middle and right).
Dendritic cells are professional antigen-presenting cells 
that play a vital role in the development of adaptive immunity 
in response to pathogens by facilitating T lymphocyte activa-
tion and diff  erentiation (19). The eff  ect of Mkp-1 knockout 
on cytokine production in dendritic cells was examined. 
Dendritic cells were derived from bone marrow isolated from 
Mkp-1+/+ and Mkp-1−/− mice by culturing in the presence 
of GM-CSF. LPS stimulation of dendritic cells resulted in 
Figure 2.  IFN-𝗄 enhances activation of p38 and JNK by inhibiting 
MKP-1 expression. Resident peritoneal macrophages were treated with 
or without 50 U/ml IFN-γ overnight before LPS stimulation (100 ng/ml) at 
the indicated times. The levels of MKP-1 protein and phosphorylated MAP 
kinases were examined using Western blotting. Please note that the order 
for the + IFN-γ samples is from right to left.134  MKP-1 SUPPRESSES ENDOTOXIC SHOCK | Zhao et al.
  signifi  cant production of TNF-α (Fig. 4 B). Remarkably, 
Mkp-1−/− cells produced  10-fold more TNF-α and 75% 
more IL-6 when compared with wild-type dendritic cells 
(Fig. 4 B, fi  rst and second panels). Interestingly, the produc-
tion of IL-10, a classic antiinfl  ammatory cytokine (20), in 
dendritic cells was also dramatically increased in Mkp-1−/− 
cells relative to the wild-type cells (Fig. 4 B, third panel). In 
contrast, IL-12 production in dendritic cells was signifi  cantly 
attenuated in Mkp-1–defi  cient cells relative to wild-type cells 
(Fig. 4 B, fourth panel). Collectively, our studies indicate that 
loss of Mkp-1 results in profound alteration in the cytokine 
expression profi  les in a variety of immune cells.
Knockout of Mkp-1 dramatically augments the biosynthesis 
of both the proinfl  ammatory cytokine TNF-𝗂 and the 
antiinfl  ammatory cytokine IL-10 in vivo
To study the role of MKP-1 in the regulation of cytokine 
production in vivo, Mkp-1+/+ and Mkp-1−/− mice were in-
jected i.p. either with vehicle (PBS) or with diff  erent doses 
of LPS. Neither Mkp-1+/+ nor Mkp-1−/− mice injected with 
PBS produced a detectable amount of TNF-α or IL-6 in 
their plasma (Fig. 5 A). Compared with wild-type animals, 
Mkp-1−/− mice were more sensitive to LPS and produced 
signifi  cantly higher levels of both TNF-α (Fig. 5 A, left) 
and IL-6 (Fig. 5 A, right) over a broad range of LPS doses. 
A time course of cytokine production in response to LPS 
was also examined in Mkp-1+/+ and Mkp-1−/− mice. In the 
absence of LPS challenge, serum levels of TNF-α, IL-6, and 
IL-10 were undetectable (Fig. 5 B). In response to LPS 
  challenge, serum TNF-α levels in Mkp-1+/+ mice were sub-
stantially elevated within 1 h followed by a rapid decline 
thereafter (Fig. 5 B, left). In Mkp-1−/− mice challenged with 
LPS, serum TNF-α levels were 3.5-fold higher than those of 
Mkp-1+/+ mice at 1 h, and the levels continued to increase 
at 2 h. By 2 h, the serum TNF-α levels in Mkp-1−/− mice 
were  29-fold higher than those in Mkp-1+/+ mice. Al-
though TNF-α levels in Mkp-1−/− mice declined substan-
tially by 3 h, the levels of TNF-α remained signifi  cantly 
higher than those in wild-type mice. In fact, TNF-α levels 
in Mkp-1−/− mice at 3 h were not signifi  cantly diff  erent 
from the maximal TNF-α levels observed in Mkp-1+/+ mice 
at 1 h (Fig. 5 B, left). In Mkp-1+/+ mice, serum IL-6 was el-
evated within 1 h and plateaued by 2 h (Fig. 5 B, middle). 
Compared with Mkp-1+/+ mice, Mkp-1−/− mice produced 
substantially more IL-6. Furthermore, serum IL-6 levels in 
Mkp-1−/− mice continued to increase through the observed 
3-h period. Similar to TNF-α, IL-10 was increased tran-
siently in Mkp-1+/+ mice (Fig. 5 B, right). On the contrary, 
LPS-induced serum IL-10 in Mkp-1−/− mice remained elevated 
Figure 3.  Knockout of Mkp-1 alters cytokine expression in macro-
phages. (A) Cytokine production by IFN-γ–primed resident peritoneal 
macrophages. Resident peritoneal macrophages primed with IFN-γ over-
night were stimulated with LPS for 4 and 6 h. Cytokine concentrations in 
the medium were analyzed by ELISA. Data are presented as the mean 
± SEM (n = 3 in each group). *, Mkp-1−/− different from Mkp-1+/+, 
P < 0.001. (B) Cytokine production by thioglycollate-elicited peritoneal 
macrophages after stimulation with 100 ng/ml LPS for 4 and 6 h. Data are 
presented as mean ± SEM (n = 4 in each group). *, Mkp-1−/− different 
from Mkp-1+/+, P < 0.05; #, Mkp-1−/− different from Mkp-1+/+, 
P < 0.005. (C) Cytokine production by unprimed resident peritoneal mac-
rophages from both Mkp-1+/+ and Mkp-1−/− mice. Resident peritoneal 
macrophages were stimulated with 100 ng/ml LPS for the indicated times, 
and cytokine concentrations in the medium were assayed by ELISA. Data 
are presented as the mean ± SEM (n = 6 in each group). *, Mkp-1−/− 
different from Mkp-1+/+, P < 0.001. (D) Expression of TNF-α, IL-6, 
IL-12p35, and IL-12p40 mRNA in LPS-stimulated wild-type and Mkp-1−/− 
resident peritoneal macrophages. Resident peritoneal macrophages were 
primed overnight with 50 U/ml IFN-γ and then stimulated with 100 ng/ml 
LPS for 4 h. qRT-PCR was performed to assess the levels of mRNA for 
TNF-α, IL-6, IL-12p35, and IL-12p40. The relative mRNA levels were nor-
malized to the GAPDH mRNA. Values represent expression levels relative 
to those in wild-type cells. Data are means ± SEM of three independent 
experiments. *, different from Mkp-1−/− cells, P < 0.05.JEM VOL. 203, January 23, 2006  135
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throughout the 3-h experimental period (Fig. 5 B, right). 
Collectively, our results indicate that Mkp-1 knockout has 
profound eff  ects on the production of TNF-α, IL-6, and 
IL-10 in vivo.
Defi  ciency in Mkp-1 renders mice susceptible to endotoxin 
shock and multiple organ failure
TNF-α is a pivotal infl  ammatory cytokine that plays an im-
portant role in the pathogenesis of septic shock (21, 22). Be-
cause Mkp-1−/− mice exhibited a marked elevation in TNF-α 
upon LPS challenge, we examined the eff  ect of Mkp-1 de-
fi   ciency on survival. Both Mkp-1+/+ and Mkp-1−/− mice 
were injected i.p. with LPS, and survival of these animals was 
monitored over 4–5 d. An LPS dose of 5 mg/kg body weight 
resulted in severe distress in both Mkp-1+/+ and Mkp-1−/− 
mice. For Mkp-1 knockout mice, mortality was observed 
within 22 h after LPS challenge (Fig. 6 A). By 32 h, 83% of 
the Mkp-1−/− mice had died, and no further death was noted 
through 120 h. In contrast, for the Mkp-1+/+ mice, the fi  rst 
mortality occurred at 34 h. By the end of the experiment 
(120 h), only 25% of the Mkp-1+/+ mice had died (Fig. 6 A). 
An LPS dose of 1.5 mg/kg body weight caused few signs 
of distress in the Mkp-1+/+ mice, and all Mkp-1+/+ mice 
  survived through the 96-h period (Fig. 6 B). However, the 
Mkp-1−/− mice given 1.5 mg/kg LPS were severely dis-
tressed, and 75% of them died over the 96-h experimental 
period (Fig. 6 B).
To examine the eff  ects of Mkp-1 defi  ciency on the func-
tion of key organs, wild-type and Mkp-1−/− mice were chal-
lenged with either vehicle (PBS) or LPS at a dose of 1.5 mg/
      kg body weight and killed 24 h after LPS injection. Blood 
Figure 4.  Knockout of Mkp-1 shifts the pattern of cytokine ex-
pression in splenocytes and dendritic cells. (A) Cytokine expression in 
LPS-stimulated splenocytes. Splenocytes isolated from Mkp-1+/+ and 
Mkp-1−/− mice were stimulated with 100 ng/ml LPS for the indicated 
times, and cytokine concentrations in the medium were assayed by ELISA. 
IFN-γ levels were measured 24 h after LPS treatment. Data are presented 
as the mean ± SEM (n = 3–9 for each group). *, Mkp-1−/− different from 
Mkp-1+/+, P < 0.05. (B) Cytokine production by bone marrow–derived 
dendritic cells from both Mkp-1+/+ and Mkp-1−/− mice. Cells were stimu-
lated with 1 µg/ml LPS for 24 h. Data are presented as mean ± SEM 
(n = 3 in each group). *, Mkp-1−/− different from Mkp-1+/+, P < 0.05; 
#, Mkp-1−/− different from Mkp-1+/+, P < 0.005.
Figure 5.  Defi  ciency in Mkp-1 enhances LPS-triggered production 
of TNF-𝗂, IL-6, and IL-10 in vivo. (A) Both Mkp-1+/+ and Mkp-1−/− 
mice were injected i.p. with either vehicle (PBS) or LPS at indicated doses. 
Mice were killed 90 min later and plasma cytokine concentrations were 
measured by ELISA. Data are presented as mean ± SEM (n = 6 in each 
group). Two-way ANOVA demonstrates a signifi  cant effect of both geno-
type (P < 0.001) and LPS dose (P = 0.005) on TNF-α and IL-6 concentra-
tions. (B) Mice were injected i.p. with LPS (1.5 mg/kg body weight) and 
killed at the indicated times. Serum cytokines were measured using ELISA. 
Data are presented as mean ± SEM (n = 10). Two-way ANOVA demon-
strates a signifi  cant effect of both genotype and time after LPS challenge 
on TNF-α, IL-6, and IL-10 concentrations (P < 0.001).
Figure 6.  Increased mortality in Mkp-1 knockout mice in response 
to LPS challenge. (A) Survival curves of Mkp-1+/+ and Mkp-1−/− mice 
after challenge i.p. with 5 mg LPS per kg body weight. Kaplan-Meier anal-
ysis demonstrates a signifi  cant difference in survival between Mkp-1+/+ 
and Mkp-1−/− mice (P < 0.001; n = 12 in each group). (B) Survival curves 
of Mkp-1−/− mice and their wild-type littermates after challenge i.p. with 
1.5 mg LPS per kg body weight (P < 0.0005; n = 12 in each group).136  MKP-1 SUPPRESSES ENDOTOXIC SHOCK | Zhao et al.
samples were collected, and blood urea nitrogen (BUN) 
  levels, a measurement of renal function, were measured (Fig. 
7 A, left). BUN levels in vehicle-treated mice were similar in 
both Mkp-1+/+ and Mkp-1−/− mice (16.3 ± 1.3 vs. 17.0 ± 
3.4 mg/dl, respectively). LPS challenge did not result in a 
  signifi  cant change in BUN for Mkp-1+/+ mice. However, 
a sub      stantial increase in BUN levels was observed in Mkp-
1−/− mice after LPS challenge (89.1 ± 12.6 mg/dl). Blood 
alanine aminotransferase (ALT) activity, an indication of liver 
damage, was measured (Fig. 7 A, right). There was no signifi  -
cant diff  erence in ALT levels between vehicle-treated Mkp-
1+/+ and Mkp-1−/− mice (25.8 ± 2.4 vs. 17.9 ± 2.4 U/liters, 
respectively). Although LPS challenge did not signifi  cantly 
change blood ALT levels in Mkp-1+/+ mice, challenge of 
Mkp-1−/− mice with LPS resulted in a signifi  cant increase in 
blood ALT levels (Fig. 7 A, right). Although the ALT levels 
in LPS-challenged wild-type mice were 22.7 ± 2.8 U/liters, 
ALT levels in LPS-challenged Mkp-1−/− mice were in-
creased to 149.2 ± 3.6 U/liters.
Because respiratory failure is often associated with septic 
shock syndrome, we examined the eff  ect of Mkp-1 defi  ciency 
on lung histology. Lung tissues were fi  xed with formalin at a 
constant distending pressure of 25 cm H2O. The lung sec-
tions were stained with hematoxylin and eosin. The lungs 
from Mkp-1−/− mice appeared normal, and there were no dif-
fere        nces observed in lung histology between vehicle-treated 
Mkp-1+/+ and Mkp-1−/− mice (not depicted). However, 
  after LPS challenge, massive infi  ltration of leukocytes in the 
interstitial spaces, marked thickening of the alveolar septa, 
and pulmonary edema were observed in lungs from Mkp-
1−/− mice, but not in lungs from Mkp-1+/+ mice (Fig. 7 B). 
Collectively, our results indicate that Mkp-1−/− but not Mkp-
1+/+ mice are highly susceptible to the development of mul-
tiple organ failure syndrome after LPS administration.
Mkp-1 knockout mice develop severe hypotension in 
response to LPS challenge
Hypotension is a clinical characteristic of severe sepsis and 
plays an important role in the pathophysiology of septic 
shock and multiple organ failure syndrome. To understand 
the role of MKP-1 in the regulation of vasculature function, 
we measured systemic blood pressure in both Mkp-1+/+ and 
Mkp-1−/− mice after LPS challenge (Fig. 8 A). For Mkp-
1+/+ mice, LPS challenge at a dose of 1.5 mg/kg resulted in 
no signifi  cant change in systolic blood pressure. In contrast, 
LPS challenge led to a substantial decrease in systolic blood 
pressure in Mkp-1−/− mice. By 4 h after LPS challenge, the 
systolic pressure in Mkp-1−/− mice decreased from 94.2 ± 
3.0 mmHg to 41.5 ± 12.5 mmHg (P < 0.005). Further-
more, the severe hypotension in the LPS-challenged Mkp-
1−/− mice persisted at 24 h (Fig. 8 A). Nitric oxide plays a 
critical role in the regulation of vasculature function. Blood 
samples were collected from both wild-type and Mkp-1−/− 
mice 24 h after LPS challenge (1.5 mg/kg body weight), 
and plasma nitrate levels were measured (Fig. 8 B). Plasma 
nitrate levels were signifi  cantly higher in the Mkp-1−/− mice 
than in Mkp-1+/+ mice after LPS challenge. Collectively, 
these observations indicate a critical regulatory role of MKP-
1 in modulating the infl   ammatory responses to LPS and 
demonstrate that lack of MKP-1 markedly sensitizes mice 
to septic shock.
Figure 7.  LPS causes renal, heptic, and pulmonary damages in 
Mkp-1−/− mice. Mice were challenged with LPS (1.5 mg/kg body weight) 
and killed 24 h later. Plasma BUN and ALT activity were measured. Lungs 
were perfused and fi  xed with formalin, and 4-μm sections were stained 
with hematoxylin and eosin. (A) BUN and ALT activities in vehicle- and 
LPS-challenged mice. Data are presented as mean ± SEM of 8–13 inde-
pendent experiments. *, P < 0.001, one-way ANOVA comparing Mkp-1+/+ 
with Mkp-1−/− groups. (B) Representative images of lung sections from 
LPS-challenged wild-type and Mkp-1−/− mice.
Figure 8.  LPS challenge results in hypotension and increased 
  nitric oxide production in Mkp-1−/− mice. Mkp-1+/+ and Mkp-1−/− 
mice were injected i.p. with LPS (1.5 mg/kg body weight). (A) Systolic 
blood pressure in mice injected with LPS. Data are presented as mean ± 
SEM of six independent experiments. *, 4 and 24 h different from control 
(0 h), P < 0.001; †, Mkp-1−/− different from Mkp-1+/+ at same time 
point, P < 0.05. (B) Plasma nitrate levels. Mkp-1+/+ and Mkp-1−/− mice 
were injected i.p. with LPS and killed 24 h later. Plasma nitrate levels 
were measured by chemiluminescence. Data are presented as the mean 
± SEM of four independent experiments. *, Mkp-1−/− different from 
Mkp-1+/+, P < 0.05.JEM VOL. 203, January 23, 2006  137
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DISCUSSION
In this report, we have demonstrated that MKP-1 is a critical 
negative regulator in the innate immune response to LPS. 
We have found that MKP-1 is induced by LPS and plays a 
critical role in the attenuation of both JNK and p38 in peri-
toneal macrophages (Fig. 1). We showed that deletion of the 
Mkp-1 gene resulted in a prolonged activation of JNK and 
p38 after LPS stimulation, leading to augmented production 
of the proinfl  ammatory cytokines TNF-α and IL-6 in mac-
rophages (Fig. 3). Although the prolonged JNK and p38 
  activation was only demonstrated experimentally in thiogly-
collate-elicited peritoneal macrophages, we found that LPS 
stimulation also resulted in a substantial increase in the pro-
duction of TNF-α and IL-6 in Mkp-1–defi  cient splenocytes 
and dendritic cells (Fig. 4). This observation strongly suggests 
that MKP-1 plays a similar regulatory role in these cell types. 
The fact that Mkp-1–defi  cient mice produced dramatically 
more TNF-α and IL-6 after LPS challenge further validates 
the critical role of MKP-1 in the control of these two proin-
fl  ammatory cytokines in vivo (Fig. 5). The substantial in-
crease in mortality after LPS challenge in Mkp-1–defi  cient 
mice illustrates the critical importance of the MKP-1–depen-
dent regulatory mechanism in host defense (Fig. 6). The 
  severe hypotension (Fig. 8) and dysfunction of vital organs 
(Fig. 7) in LPS-challenged Mkp-1–defi  cient mice are consis-
tent with the clinical symptoms of septic shock. These results 
clearly indicate that MKP-1 acts as a vital suppressor of the 
infl  ammatory responses and thereby protects the host from 
shock, multiple organ failure, and mortality upon exposure 
to LPS. Our results also raise the possibility that variations 
in the MKP-1 gene may represent a susceptibility factor for 
septic shock.
What is the mechanism through which MKP-1 controls 
the infl  ammatory cascade and prevents shock and multiple 
organ failure in the host? First, by inactivating JNK and p38, 
MKP-1 determines the window of synthesis of proinfl  am-
matory cytokines, including TNF-α. In this sense, MKP-1 
serves as a servocontrol mechanism for TNF-α production. 
In the absence of the MKP-1–mediated servocontrol mecha-
nism, the signal directing TNF-α synthesis is not appropri-
ately down-regulated, thus resulting in the overproduction of 
proinfl   ammatory cytokines. Previously, it has been shown 
that both JNK and p38 positively regulate TNF-α biosynthe-
sis by stabilizing TNF-α mRNA and enhancing its translation 
(12, 23). Thus, it is plausible that both the stability and the 
translation of TNF-α mRNA are enhanced as the result of 
sustained JNK and p38 activation in Mkp-1−/− cells, explain-
ing the prolonged TNF-α biosynthesis in Mkp-1−/− mice 
  after LPS challenge (Fig. 5 B). A potential explanation for 
the shock and multiple organ dysfunction is that the excessive 
TNF-α triggers a considerable elevation in nitric oxide syn-
thase activity (24, 25), resulting in severe hypotension that 
leads to hypoperfusion and multiple organ failure (Fig. 8).
A balance between activation and subsequent deacti-
vation of the immune system is of critical importance in the 
host immunological defenses. Although activation of the sig-
nal transduction cascades is critical for mounting an aggres-
sive immune response to eliminate invading pathogens, 
deactivation of the signaling pathways restrains the poten-
tially devastating actions of the immunological system on the 
host, thus preventing self-destruction. A variety of negative 
regulators operate at various steps in the critical signal trans-
duction pathways downstream of TLRs. These negative reg-
ulators modulate the strength and duration of the transduced 
signals and control the production of infl  ammatory cytokines 
(26). It has been shown that TLR4 is transiently suppressed 
in response to LPS (27). In addition to the modulation at 
the receptor level, several antiinfl  ammatory proteins are also 
induced, which include IL-1 receptor–associated kinase 
(IRAK)-M, suppressor of cytokine signaling (SOCS)-1, in-
hibitor-κB, MKP-1, and antiinfl  ammatory cytokines such as 
IL-10 (26). Through these inhibitory proteins, cells not only 
terminate the signaling cascade at the cell surface, but also 
switch off   downstream mediators, thus silencing the signal  -
ing pathways leading to the production of proinfl  ammatory 
cytokines. Therefore, a timely “switch-off  ” of the signaling 
events is crucial, as it not only prevents the overproduction 
of the potentially harmful cytokines, but also prepares the 
cells for responding to subsequent pathogenic infection. The 
discovery of MKP-1 as a crucial negative regulator of the 
  innate immune responses both in vivo and in vitro places it 
in the center of the complex negative regulatory mechanism 
dictating endotoxin tolerance. Although similarities exist 
  between phenotypes of Mkp-1 knockout mice and mice 
lacking other negative regulators, there are also important 
diff  erences. It appears that knockout of Irak-m or Socs-1 leads 
to generalized hyperresponses of innate cells to LPS chal-
lenge (28, 29), whereas deletion in the Mkp-1 gene changes 
the pattern of innate immune responses. For example, knock-
out of either Irak-m or Socs-1 resulted in an increase in IL-12 
production after LPS stimulation (28, 29). In contrast, knock-
out of Mkp-1 leads to decreased LPS-induced IL-12 pro-
duction (Figs. 3 and 4). The phenotypical diff  erences between 
Mkp-1 knockout mice and Irak-m or Socs-1 knockout mice 
likely refl  ect the diff  erent mechanisms on which these regu-
lators operate.
There are at least 11 MKPs in mammalian cells (30). Al-
though this group of phosphatases exhibit diff  erential sub-
strate specifi  cities toward diff  erent MAP kinases, many of 
the phosphatases also share substrates. For example, MKP-1 
has been shown to prefer p38 and JNK as substrates (31), 
  although it was originally characterized as an ERK phospha-
tase (32). In contrast, phosphatase of activated cells 1, an MKP 
predominantly expressed in hematopoietic cells, prefer entially 
inactivates ERK and p38 (33). In macrophages, at least four 
MKPs are expressed: MKP-1, MKP-2, phosphatase of acti-
vated cells 1, and MKP-5/MKP-M (13, 34). It is possible that 
multiple MKPs act cooperatively to control the MAP kinase 
cascades. In the absence of MKP-1 protein, JNK and p38 will 
be eventually inactivated by other MKPs, albeit at a much 
slower rate. This is consistent with the observation that de-
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  macrophages was delayed. The fi  nding that inactivation of 
ERK was not aff  ected by the knockout of the Mkp-1 gene 
(Fig. 1) further supports the notion that MKP-1 does not play 
a signifi  cant role in the inactivation of ERK in our system. 
Recently, Zhang et al. (35) demonstrated that MKP-5 acts as 
a JNK phosphatase and plays an important role in the regula-
tion of both innate and adaptive immune responses. Whether 
knockout of Mkp-1 has an appreciable impact on the adaptive 
immunity remains to be addressed. Although it has not been 
reported whether knockout of Mkp-5 also sensitizes mice to 
endotoxin shock, it is tempting to speculate that the endo-
toxin-induced phenotype of Mkp-5 knockout may be less 
  severe than that of Mkp-1 knockout. MKP-5 has been found 
to only regulate the JNK pathway, whereas MKP-1 regu  -
lates both the JNK and p38 pathways. Considering that the 
JNK and the p38 pathways regulate both related and distinct 
cellular functions (36, 37), knockout of Mkp-1 may perturb 
more cellular processes and have a more severe consequence 
than the Mkp-5 deletion. Perhaps refl  ecting diff  erent sever  -
ity, the diff  erences in blood TNF-α levels between Mkp-5 
knockout mice and their wild-type littermates were relatively 
modest (less than twofold; reference 35). In contrast, the dif-
ference between the blood TNF-α levels in Mkp-1–defi  cient 
mice and their wild-type littermates after LPS challenge was 
dramatic (almost 30-fold; Fig. 5).
Another intriguing fi  nding from this study is that Mkp-1 
defi  ciency also leads to elevated production of IL-10 both in 
isolated cells and in vivo. These results indicate that IL-10 is 
regulated in a fashion similar to TNF-α, suggesting that the 
IL-10–mediated antiinfl  ammatory mechanism is hardwired 
in the cells to counterbalance the actions of proinfl  ammatory 
cytokines. Interestingly, it has been shown that p38 is crucial 
for the production of IL-10 during LPS stimulation (38, 39). 
Therefore, the increase in IL-10 production in Mkp-1−/− 
cells may be a refl  ection of the increase in p38 activity. The 
down-regulation of IL-12 and IFN-γ observed in Mkp-1–
defi  cient cells was also an interesting and unexpected fi  nd  -
ing (Figs. 3 and 4). Although the mechanisms mediating their 
down-regulation are unclear, two potential mechanisms may 
be involved. First, IL-10 is a potent antiinfl  ammatory cyto-
kine (20, 40). The profound increase in IL-10 secretion after 
LPS stimulation may down-regulate the expression of the 
classic Th1 cytokines IL-12 (Fig. 3 D) and IFN-γ through an 
autocrine system. Indeed, it has been reported that IL-10 
  inhibits IL-12 expression in dendritic cells (41). Second, al-
though less likely, JNK and/or p38 may negatively regulate 
the expression of IL-12 and IFN-γ. Thus, loss of MKP-
1–mediated attenuation of these pathways may lead to the 
down-regulation of these cytokines. It is worth noting that 
IFN-γ can also infl  uence Mkp-1 expression (Fig. 2). Such a 
regulation likely has important biological signifi  cance. It has 
long been known that IFN-γ can boost the antimicrobial ac-
tivity of macrophages and substantially enhance the secretion 
of TNF-α by macrophages (16). We found that IFN-γ can 
attenuate LPS-induced Mkp-1 expression and prolong the 
activation of both JNK and p38. It is plausible that the pro-
longation of these MAP kinase pathways contributes to the 
biological activities of IFN-γ.
In summary, we found that Mkp-1 knockout prolonged 
the activation of p38 and JNK in LPS-stimulated macro-
phages. This prolonged activation of p38 and JNK was asso-
ciated with substantially elevated production of TNF-α and 
IL-6 in macrophages. Furthermore, Mkp-1 knockout mice 
demonstrated a substantial increase in mortality after LPS 
treatment compared with wild-type mice. LPS treatment of 
Mkp-1 knockout mice resulted in renal, hepatic, and pul-
monary dysfunction. Collectively, our fi  ndings demonstrate 
the essential role of Mkp-1 in containing the host immune 
response to bacterial products. The unexpected fi  ndings that 
Mkp-1 defi  ciency resulted in decreased IL-12 and IFN-γ but 
increased IL-10 production suggest that Mkp-1 regulation of 
the immune response is more complex than simply down-
regulation of proinfl  ammatory cytokine production. We spec-
ulate that Mkp-1 may represent a pharmacological target for 
treatment of patients with endotoxic shock, and that poly-
morphisms in the MKP-1 gene may result in greater suscep-
tibility to endotoxic shock.
MATERIALS AND METHODS
Animals. Cryopreserved embryos of Mkp-1 knockout mice (Mkp-1+/− and 
Mkp-1−/−) were provided by Bristol-Myers Squibb Pharmaceutical Re-
search Institute and regenerated into mice at The Jackson Laboratory. These 
mice were bred in-house to yield both Mkp-1+/+ and Mkp-1−/− mice. All 
animals received humane care and all animal-related work was performed in 
accordance with National Institutes of Health guidelines. The experimental 
protocols were approved by the Institutional Animal Care and Use Commit-
tee of the Columbus Children’s Research Institute.
Isolation of peritoneal macrophages, splenocytes, and dendritic cells. 
Peritoneal macrophages were isolated from naive Mkp-1+/+ or Mkp-1−/− 
mice by peritoneal lavage. The resident peritoneal macrophages were cul-
tured overnight in RPMI 1640 medium (Mediatech) supplemented with 5% 
FBS (Hyclone Laboratories) and 50 U/ml IFN-γ (Calbiochem) before being 
stimulated with 100 ng/ml LPS (Escherichia coli O127:B8) purchased from 
Sigma-Aldrich. To isolate elicited peritoneal macrophages, mice were in-
jected i.p. (2 ml/mouse) with 3% Brewer Thioglycollate Medium (BD 
  Diagnostic) and cells were harvested 4 d later. Splenocytes were isolated, 
cultured in RPMI 1640 medium containing 10% FBS, and stimulated with 
100 ng/ml LPS. Bone marrow–derived dendritic cells were prepared as de-
scribed previously (42). In brief, bone marrow cells depleted of T and B cells 
were cultured for 5 d in RPMI 1640 medium supplemented with 5% FBS 
and 10 ng/ml of recombinant murine GM-CSF (BD Biosciences). Cells 
were replated and matured in 1 μg/ml LPS (Escherichia coli O55:B55; Sigma-
Aldrich) for 24 h.
Western blotting, immune complex kinase assays, and ELISA. West-
ern blot analysis was performed using antibodies against MKP-1 (Santa Cruz 
Biotechnology, Inc.), phosphorylated JNK, p38, and ERK, as well as phos-
phorylated MK2 (Cell Signaling Technology). MK-2 activity was measured 
by immune complex kinase assays using [γ-32P]ATP and recombinant mouse 
Hsp25 (StressGen Biotechnologies) as a substrate as described previously 
(14). TNF-α, IL-6, IL-10, IL-12, and IFN-γ in the culture medium were 
determined using ELISA as described previously (43).
qRT-PCR. Resident peritoneal macrophages isolated from naive Mkp-
1+/+ or Mkp-1−/− mice were primed overnight with 50 U/ml IFN-γ and 
then stimulated with 100 ng/ml LPS (Escherichia coli O127:B8) for 4 h. Total 
RNA was isolated using Trizol (Invitrogen), digested with RNase-free JEM VOL. 203, January 23, 2006  139
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  DNase I, and purifi  ed with RNeasy MinElute Cleanup kit (QIAGEN). 
First-strand cDNA was synthesized with 1.5 μg total RNA using Moloney 
murine leukemia virus reverse transcriptase (Invitrogen). qRT-PCR was 
performed by the comparative threshold cycle (∆CT) method and normal-
ized to GAPDH. The primers used for GAPDH, IL-6, IL-12p35, and IL-
12p40 were as described previously (41). The following primers were used 
for TNF-α: 5′-CCCCAAAGGGATGAGAAGTT  -3′ (forward) and 5′-
CACTTGGTGGTTTGCTACGA  -3′ (reverse).
LPS injection and endotoxin shock. Mkp-1+/+ or Mkp-1−/− mice were 
injected i.p. with PBS or the designated doses of LPS dissolved in LPS. 
Plasma or serum was assayed for cytokine levels using ELISA. Plasma BUN 
and ALT activity was measured using Infi  nity Urea and ALT kits (Thermo 
Electron), respectively. Lungs were fi  rst perfused with 10% formalin at con-
stant distending pressure of 25 cm H2O for 10 min, excised from the animals, 
and then placed in 10% formalin overnight at 4°C. 4-μm sections were pre-
pared and stained with hematoxylin and eosin. Systolic blood pressures were 
determined noninvasively by tail cuff   monitor (44). Plasma nitrate levels 
were measured by chemiluminescence (45).
Statistic analysis. The in vitro cytokine production was compared between 
Mkp-1+/+ and Mkp-1−/− cells using one-way analysis of variance (ANOVA). 
Plasma ALT levels were log-transformed before analysis using one-way 
ANOVA. One-way ANOVA was used to analyze the diff  erences in plasma 
BUN and nitrate levels as well as in systolic blood pressures between Mkp-
1+/+ and Mkp-1−/− mice. Plasma or serum cytokine concentrations between 
Mkp-1+/+ and Mkp-1−/− mice with or without in vivo LPS challenge were 
analyzed using two-way ANOVA. When ANOVA demonstrated diff  er-
ences, a modifi  ed t test was used to identify diff  erences. Diff  erences in sur-
vival between Mkp-1+/+ and Mkp-1−/− mice after LPS challenge were 
determined by Kaplan-Meier analysis. All tests were performed using SPSS 
13.01 software (SPSS Inc.). A p-value <0.05 was considered signifi  cant.
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